Drug Database
Back to search

Poland· PL-100173022

Diacomit

A stiripentol product containing stiripentolum, registered in Poland by Biocodex. The same ATC class is registered in 17 of our 19 countries.

ATC N03AX17

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDiacomitATCN03AX17REGISTER NO.PL-100173022PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about stiripentolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Stiripentol is registered in 17 of 19 countries.

Countries holding a registration under ATC N03AX17 (stiripentol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search stiripentol products by name

Stiripentol · ATC N03AX17

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of stiripentol costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Stiripentol · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$16.74
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Stiripentolum
Manufacturer
Biocodex
Country
Poland (PL)
ATC code
N03AX17
ATC class
Stiripentol
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

1 priced
  • gtin
    05909990017331
    60 sasz.
    PLN 1623.43
  • gtin
    05909990017348
  • gtin
    05909990017324

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

307 interactions on record for stiripentol.

Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check stiripentol against other medicinesHow interaction checks work

Stiripentol · interactions on record

307 records

  • 40 severe
  • 260 moderate
  • 7 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • NaloxegolA06AH03severe
  • EliglustatA16AX10severe
  • CilostazolB01AC23severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Stiripentol in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All stiripentol products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Stiripentol, Stiripentol Kinedexe Uk
  • Iceland · Diacomit
  • Liechtenstein · Diacomit
  • Netherlands · Stiripentol Billev
  • Norway · Diacomit

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b0c78c2d-6603-4e20-b918-37458325d8ad
GET /v1/drugs/b0c78c2d-6603-4e20-b918-37458325d8ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania zawiesiny doustnej",
  "source": "urpl",
  "strength": "500 mg",
  "packaging": "05909990017324 ¦ Rpz ¦ EU/1/06/367/010 ¦ 21500\n30 sasz. 500 mg\n05909990017331 ¦ Rpz ¦ EU/1/06/367/011 ¦ 21501\n60 sasz. 500 mg\n05909990017348 ¦ Rpz ¦ EU/1/06/367/012 ¦ 21511\n90 sasz. 500 mg",
  "substance": "stiripentolum 500 mg",
  "common_name": "Stiripentolum",
  "pl_product_id": "100173022",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about stiripentol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console